Bayer gets green light to sell long-acting hemophilia A therapy as Roche muscles in with Hemlibra https://t.co/D6Gk6iLfxb — Marisa Peer (@PeerMarisa) August 30, 2018
Bayer gets green light to sell long-acting hemophilia A therapy as Roche muscles in with Hemlibra https://t.co/D6Gk6iLfxb
No comments:
Post a Comment